Phase I/II randomized trial of aerobic exercise in Parkinson disease in a community setting. - Wikidata - wikimedia - TriplyDB

Phase I/II randomized trial of aerobic exercise in Parkinson disease in a community setting.

Phase I/II randomized trial of aerobic exercise in Parkinson disease in a community setting.

http://www.wikidata.org/entity/Q34043757

about

Interventions for fatigue in Parkinson's disease Pathophysiology of Motor Dysfunction in Parkinson's Disease as the Rationale for Drug Treatment and Rehabilitation A Concerted Action Of Estradiol And Insulin Like Growth Factor I Underlies Sex Differences In Mood Regulation By Exercise.Time after time: environmental influences on the aging brain Nonpharmacological treatments for patients with Parkinson's disease.Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium.Establishing an evidence-base framework for driving rehabilitation in Parkinson's disease: A systematic review of on-road driving studies.Medial frontal ∼4-Hz activity in humans and rodents is attenuated in PD patients and in rodents with cortical dopamine depletion.Exercise improves cognition in Parkinson's disease: The PRET-PD randomized, clinical trial.The Therapeutic Potential of Exercise to Improve Mood, Cognition, and Sleep in Parkinson's Disease Current Pharmaceutical Treatments and Alternative Therapies of Parkinson's Disease.Quality improvement in neurology: Parkinson disease update quality measurement set: Executive summary.On the Run for Hippocampal Plasticity.New clinical trials for nonmotor manifestations of Parkinson's disease.Therapies for Parkinson's diseases: alternatives to current pharmacological interventions.The Effects of Physical Activity in Parkinson's Disease: A Review.Startle Habituation and Midfrontal Theta Activity in Parkinson Disease.Effects of Nordic walking training on functional parameters in Parkinson's disease: a randomized controlled clinical trial.Evaluating rehabilitation interventions in Parkinson's disease with functional MRI: a promising neuroprotective strategy.Physical Exercise Modulates L-DOPA-Regulated Molecular Pathways in the MPTP Mouse Model of Parkinson's Disease.The Effect of Aerobic Exercise on Brain-Derived Neurotrophic Factor in People with Neurological Disorders: A Systematic Review and Meta-Analysis.High-Intensity Exercise Acutely Increases Substantia Nigra and Prefrontal Brain Activity in Parkinson's Disease.Effect of High-Intensity Treadmill Exercise on Motor Symptoms in Patients With De Novo Parkinson Disease: A Phase 2 Randomized Clinical Trial.Lee Silverman Voice Treatment (LSVT)-BIG to improve motor function in people with Parkinson's disease: a systematic review and meta-analysis.Uncertainty and depression in people with Parkinson's disease: A cross-sectional study.Aerobic Exercise Improves Mood, Cognition, and Language Function in Parkinson's Disease: Results of a Controlled Study.Cognitive Rehabilitation in Parkinson's Disease: Is it Feasible?Movement-Based Priming: Clinical Applications and Neural Mechanisms.Aerobic fitness is associated with inhibitory control in persons with multiple sclerosis.Effects of coordination and manipulation therapy for patients with Parkinson disease.Dual tasking in Parkinson's disease: Cognitive consequences while walking.Physical Activity in Early Parkinson Disease.Mild Cognitive Impairment in Parkinson's Disease-What Is It?Cognitive impairment in Parkinson's disease: a report from a multidisciplinary symposium on unmet needs and future directions to maintain cognitive health.Effects of Physical Activity on Walking in Individuals with Parkinson’s Disease

P2860

Q24186581-EF1D5247-AEBF-4C33-8603-62F34C674360 Q26745654-FD9C6B4B-72AE-4A38-A848-0D2B4D06B725 Q27315057-311F37C8-BD41-4B70-A7BD-8815EA06E1F8 Q28393593-A8107242-5928-4CC1-B26C-187E988976B5 Q30377906-EDD28C19-9708-40B4-A4CD-6E71ABEE87A3 Q33869820-BD6D251A-0D18-46DC-85C8-D587CC84F121 Q35789351-9FCBB6A0-F969-4970-940E-585ACB9A83D4 Q36106564-F4555F7F-59A8-48E4-A3B9-19046D547128 Q36172423-8DA75681-56B4-4FB1-8EA7-A18FB791DABF Q36494212-1C0820AD-0D6F-4E8F-A549-2C29A7AB93D5 Q36925905-224C1B5F-0EBC-4D0F-BC00-286F8AC3E1BB Q37008911-E5BBC560-55E8-4B95-8F63-282905B84BBF Q38403023-1FA68D1D-99D2-4BE6-9022-9032390FD5E9 Q38587090-FC959837-E647-4854-95CA-65661DB3FFA2 Q38925121-68E383F8-859E-4421-92DB-69C714DD0C13 Q38938925-E3433EA1-50ED-4EF0-9609-34D71D1CDAB7 Q39601396-8CBBC214-5AF1-418A-B3C5-B007CE70D459 Q40034439-C9561717-B136-4C08-A9AB-CC50AA147959 Q41884810-B8362A71-D26D-4DF5-AA47-C23276403A95 Q42696309-B824E0CA-D0D9-4377-9BDB-873F01A2EE49 Q47133611-FF95CBC7-F154-496B-90D4-F09FA2BB06ED Q47223165-903A7F92-E6AA-4BAF-B447-4829801DB58C Q47681828-2AB67EE6-6CC5-46E9-A4F5-1B316192B9E8 Q47860248-A7004424-F6BC-4ADF-800C-5C866A7A061E Q47926740-786BAFA2-C4D7-4EEE-B0B7-6D07BA143F20 Q48038387-13080438-1D13-4389-BF5F-10711BD5ADF6 Q48091456-5DB66BA1-8796-4551-B770-74A246E2D06C Q48271274-FD770560-8C8B-43D9-B98D-3AFF0D40FA69 Q50589912-4088E329-51EF-41F9-83D8-6748239CA17C Q51772002-2960C35A-D05B-4905-819A-4C7D9BB03988 Q52098471-232019AB-2441-42DB-9511-CBE2840486B3 Q55039435-F80BD6D9-220D-4082-9D34-2C16A430C067 Q55387790-6CBC2FFF-0D7D-43C9-AC47-A8F7E88E1C64 Q55451028-D8145CBD-A087-489E-BBF5-3626BA15F2F7 Q58215188-EC62B12A-AAC8-44A5-B8DE-93C5F0C96C95

P2860

Phase I/II randomized trial of aerobic exercise in Parkinson disease in a community setting.

http://www.wikidata.org/entity/Q34043757

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Phase I/II randomized trial of ...... isease in a community setting.

@ast

Phase I/II randomized trial of ...... isease in a community setting.

@en

Phase I/II randomized trial of ...... isease in a community setting.

@nl

type

label

Phase I/II randomized trial of ...... isease in a community setting.

@ast

Phase I/II randomized trial of ...... isease in a community setting.

@en

Phase I/II randomized trial of ...... isease in a community setting.

@nl

prefLabel

Phase I/II randomized trial of ...... isease in a community setting.

@ast

Phase I/II randomized trial of ...... isease in a community setting.

@en

Phase I/II randomized trial of ...... isease in a community setting.

@nl

P1433

Q34043757-EB77A5F5-4866-40C5-A7FD-0FBCC9A32E7A

P1476

Q34043757-547C711F-8D05-4153-BC29-C4ED4FFEF8F7

P2093

Q34043757-00C17101-E3CE-418A-84B4-4E694D5B695E

Q34043757-1B51A392-92CD-454E-88EB-7A1D437F9CB6

Q34043757-277266A3-A910-4FD9-BE1C-48E5CCECAC8D

Q34043757-2DFCCAD7-845B-490C-BEA8-AFAF3BD575A3

Q34043757-52EF051C-D67B-4FF5-ACEA-806EC69B957C

Q34043757-6B8AA5F8-C61B-4AD0-8233-1C5DDFB4970A

Q34043757-766EADC3-50B8-4A58-8D97-B9F232B88D94

Q34043757-7EA4C62F-D488-4D44-A0CB-3BCEDF1B18EB

Q34043757-BF0230DF-E8C1-4125-B1B9-7F3CA5D30FBB

Q34043757-DCF28B6E-4568-44CC-9495-70E756D08DA0

P2860

Q34043757-01A6F1E2-DF5F-474E-9CC4-22B5A80C6E67

Q34043757-05BD7837-C111-4B35-8F2D-8C2AA2B67BE0

Q34043757-0622B4BD-6624-4825-9CB2-0DBCB6E87839

Q34043757-090F941D-F1DD-41D3-BD79-1F8C7E7AA6F9

Q34043757-0BD11BBD-33E9-408A-A3FD-3825FDC7AEA0

Q34043757-161DAF3F-5519-4B1E-B51B-87033195C42D

Q34043757-207CE2BF-729D-4FE1-9F26-213FA949C252

Q34043757-21E859B2-0385-40E3-92EB-AA0ACDB796B8

Q34043757-2C68D014-56E6-46C4-87BA-60F9394B0EB7

Q34043757-2DC29DEA-9B87-4C92-91CB-7E0B7DD61511

P304

Q34043757-C7DBC61D-8C5B-4A85-881B-6950DCFCFAEA

P31

Q34043757-33B03C82-5517-4775-8008-BAC1B4208FC0

P356

Q34043757-F0D298DE-1A2A-4540-ABC1-670106D2FEB2

P407

Q34043757-B5F0728E-8DB4-4B32-A7A2-737BEF1FB224

P433

Q34043757-816FE84A-7551-44E4-A86D-2E66897ECA9C

P478

Q34043757-5517B812-FA3F-403F-B1AA-5E53FE65CAE2

P50

Q34043757-30C03432-4FB7-476A-88DF-C224FBFA69F3

Q34043757-4ED2630A-DDE9-41B3-A22B-973229E65AAF

Q34043757-81E09C66-57EE-487F-9C1F-17B6DC6F72E1

Q34043757-D0AC83F6-3351-4253-8763-5847ADBB337C

Q34043757-D9FBD250-A0E4-451B-BBCE-FDA66A319451

Q34043757-DD8F64D4-6DA1-4BB5-85B6-DF5E2513EA1E

P577

Q34043757-0F96C46F-E8B8-4447-9850-85C8A237200A

P698

Q34043757-5D31B529-D7AB-4B65-A37C-52D0BB276163

P921

Q34043757-2E883EC7-C5FE-4AD2-8E90-A945A5F9CC0F

Q34043757-7EC861FB-DC94-4F2D-9C1A-F0E74A51512B

Q34043757-E4FDF44D-D802-40D1-B892-DC2293190AE2

P932

Q34043757-24769D30-D363-4C1D-98D1-61DD7251E13B

P356

WNL.0000000000000644

P1433

P1476

Phase I/II randomized trial of ...... isease in a community setting.

@en

P2093

Arthur F Kramer

http://www.w3.org/2001/XMLSchema#string

Joel Bruss

http://www.w3.org/2001/XMLSchema#string

Joel N Kline

http://www.w3.org/2001/XMLSchema#string

Matthew Rizzo

http://www.w3.org/2001/XMLSchema#string

Michelle W Voss

http://www.w3.org/2001/XMLSchema#string

Sara R Newman

http://www.w3.org/2001/XMLSchema#string

Sonya Mehta

http://www.w3.org/2001/XMLSchema#string

Teri R Thomsen

http://www.w3.org/2001/XMLSchema#string

Thomas J Grabowski

http://www.w3.org/2001/XMLSchema#string

Warren G Darling

http://www.w3.org/2001/XMLSchema#string

P2860

Does vigorous exercise have a neuroprotective effect in Parkinson disease?

The effect of Parkinson's disease on interference control during action selection.

Road safety in drivers with Parkinson disease

Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD).

A recommended scale for cognitive screening in clinical trials of Parkinson's disease.

The effect of exercise training in improving motor performance and corticomotor excitability in people with early Parkinson's disease.

Exercise-enhanced neuroplasticity targeting motor and cognitive circuitry in Parkinson's disease.

Effects of aerobic exercise on mild cognitive impairment: a controlled trial

Exercise and executive function in individuals with chronic stroke: a pilot study

Effects of aerobic exercise on selected physiological parameters and quality of life in patients with type 2 diabetes mellitus.

P304

413-425

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/WNL.0000000000000644

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

83

http://www.w3.org/2001/XMLSchema#string

P50

Vincent Magnotta

Derek R Blanchette

Kevin C Doerschug

Jeffrey D Dawson

Steven W Anderson

P577

2014-07-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24991037

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

phase I clinical trial

phase II clinical trial

P932

4132568

http://www.w3.org/2001/XMLSchema#string